Wuchereria bancrofti infection and disease in a rural area of Papua New Guinea

Papua and New Guinea Medical Journal

Volumn , Issue 3-4, 2000, Pages 166-171

  Alexander, Neal D E ^a,b  

^a PAPUA NEW GUINEA INSTITUTE OF MEDICAL RESEARCH   (Papua New Guinea)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; ARTICLE; ELEPHANTIASIS; HUMAN; PAPUA NEW GUINEA; PARASITOLOGY; RURAL POPULATION; STATISTICS; WUCHERERIA BANCROFTI;

ANIMALS; ELEPHANTIASIS, FILARIAL; HUMANS; PAPUA NEW GUINEA; RURAL POPULATION; WUCHERERIA BANCROFTI;

EID: 0034286265     PISSN: 00311480     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Michael E, Bundy DAP, Grenfeli BT. Reassessing the global prevalence and distribution of lymphatic filariasis. Parasitology 1996;112:409-428.
2. Murray CJL, Lopez AD. The Global Burden of Disease: A Comprehensive Assessment of Mortality and Disability from Diseases, Injuries, and Risk Factors in 1990 and Projected to 2020. Cambridge, Massachusetts: Harvard School of Public Health on behalf of the World Health Organization and the World Bank, 1996.
3. Dreyer G, Piessens WF. Worms and microorganisms can cause lymphatic filariasis in residents of filariasis-endemic areas. In: Nutman TB, ed. Lymphatic Filariasis. London: Imperial College Press, 2000:245-264.
4. Bockarie M, Kazura J, Alexander N, Dagoro H, Bockarie F, Perry R, Alpers MP. Transmission dynamics of Wuchereria bancrofti in East Sepik Province, Papua New Guinea. Am J Trop Med Hyg 1996;54:577-581.
5. Kazura JW, Bockarie M, Alexander N, Perry R, Bockarie F, Dagoro H, Dimber Z, Hyun P, Alpers MP. Transmission intensity and its relationship to infection and disease due to Wuchereria bancrofti in Papua New Guinea. J Infect Dis 1997;176:242-246.
6. Bockarie MJ, Alexander NDE, Hyun P, Dimber Z, Bockarie F, Ibam E, Alpers MP, Kazura JW. Randomised community-based trial of annual single-dose diethylcarbamazine with or without ivermectin against Wuchereria bancrofti infection in human beings and mosquitoes. Lancet 1998;351:162-168.
7. Alexander NDE, Perry RT, Dimber ZB, Hyun PJ, Alpers MP, Kazura JW. Acute disease episodes in a Wuchereria bancrofti-endemic area of Papua New Guinea. Am J Trop Med Hyg 1999;61:319-324.
8. Kumaraswami V. The clinical manifestations of lymphatic filariasis. In: Nutman TB, ed. Lymphatic Filariasis. London: Imperial College Press, 2000:103-125.
9. King CL, Nutman TB. Regulation of the immune response in lymphatic filariasis and onchocerciasis. Immunol Today 1991;12 Suppl:A54-A58.
10. Addiss DG, Dreyer G. Treatment of lymphatic filariasis. In: Nutman TB, ed. Lymphatic Filariasis. London: Imperial College Press, 2000:151-199.
11. Michael E, Grenfell BT, Bundy DAP. The association between microfilaraemia and disease in lymphatic filariasis. Proc R Soc Lond B Biol Sci 1994;256:33-40.
12. Grenfell BT, Michael E. Infection and disease in lymphatic filariasis: an epidemiological approach. Parasitology 1992;104 Suppl:S81-S90.
13. Partono F. The spectrum of disease in lymphatic filariasis. In: Evered D, Clark S, eds. Filariasis. Chichester: Wiley, 1987:15-31.
14. Nelson FK, Greiner DL, Shultz LD, Rajan TV. The immunodeficient scid mouse as a model for human lymphatic filariasis. J Exp Med 1991;173:659-663.
15. Price EW, Bailey D. Environmental factors in the aetiology of endemic elephantiasis of the lower legs in tropical Africa. Trop Geogr Med 1984;36:1-5.
16. Gyapong JO. The relationship between infection and disease in Wuchereria bancrofti infection in Ghana. Trans R Soc Trop Med Hyg 1998;92:390-392.
17. Kar SK, Mania J, Kar PK. Humoral immune response during filarial fever in bancroftian filariasis. Trans R Soc Trop Med Hyg 1993;87:230-233.
18. Ramaiah KD, Ramu K, Kumar KN, Guyatt H. Epidemiology of acute filarial episodes caused by Wuchereria bancrofti infection in two rural villages in Tamil Nadu, south India. Trans R Soc Trop Med Hyg 1996;90:639-643.
19. Gyapong JO, Gyapong M, Adjei S. The epidemiology of acute adenolymphangitis due to lymphatic filariasis in northern Ghana. Am J Trop Med Hyg 1996;54:591-595.
20. Rao CK, Chandrasekharan A, Cherian C. Frequency and duration of acute filarial attacks in persons in Brugia malayi endemic community. Indian J Med Res 1982;75:813-815.
21. Turner P, Copeman B, Gerisi D, Speare R. A comparison of the OG4C3 antigen capture ELISA, the Knott test, an IgG4 assay and clinical signs, in the diagnosis of bancroftian filariasis. Trop Med Parasitol 1992;44:45-48.
22. Weil GJ, Lammie PJ, Weiss N. The ICT filariasis test: a rapid-format antigen test for diagnosis of bancroftian filariasis. Parasitol Today 1997;13:401-404.
23. Dreyer G, Medeiros Z, Netto MJ, Leal NC, de Castro LG, Piessens WF. Acute attacks in the extremities of persons living in an area endemic for bancroftian filariasis: differentiation of two syndromes. Trans R Soc Trop Med Hyg 1999;93:413-417.
24. McGregor A. Washing off elephantiasis. Lancet 1994;344:121.
25. Shenoy RK, Sandhya K, Suma TK, Kumaraswami V. A preliminary study of filariasis related acute adenolymphangitis with special reference to precipitating factors and treatment modalities. Southeast Asian J Trop Med Public Health 1995;26:301-305.
26. Shenoy RK, Suma TK, Rajan K, Kumaraswami V. Prevention of acute adenolymphangitis in brugian filariasis: comparison of the efficacy of ivermectin and diethylcarbamazine, each combined with local treatment of the affected limb. Ann Trop Med Parasitol 1998;92:587-594.
27. Shenoy RK, Kumaraswami V, Suma TK, Rajan K, Radhakuttyamma G. A double-blind, placebo-controlled study of the efficacy of oral penicillin, diethylcarbamazine or local treatment of the affected limb in preventing acute adenolymphangitis in lymphoedema caused by brugian filariasis. Ann Trop Med Parasitol 1999;93:367-377.